Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara products to breast imaging clinics in the United States, Australia, New Zealand and parts of Asia. Transpara is designed to assist radiologists with the reading of mammograms and is one of the first next-generation artificial intelligence (AI) applications for detecting breast cancer in screening mammograms to gain 510(k) clearance from the U.S. Food & Drug Administration (FDA).
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure that loosens certain radiopharmaceutical bundling practices and simplifies Medicare billing for nuclear medicine procedures.
Association for Medical Imaging Management (AHRA) President Chris Tomlinson, CRA, FAHRA, and President-elect Jacqui Rose ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
DrChrono Inc. and DeepScribe announced a partnership so medical practices using DrChrono EHR can use artificial intelligence (AI) to automate medical note taking from physician appointments and integrate it right into their electronic health record (EHR).
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Philips, a global leader in health technology, today announced that it has completed the previously announced ...
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Clinical trials are a critical tool for getting new treatments to people who need them, but research shows that difficulty finding the right volunteer subjects can undermine the effectiveness of these studies. Researchers at Cincinnati Children’s Hospital Medical Center designed and tested a new computerized solution that used artificial intelligence (AI) to effectively identify eligible subjects from electronic health records (EHRs), allowing busy clinical staff to focus their limited time on evaluating the highest quality candidates.
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have been published by an international multidisciplinary working group1. In addition, data from the Dosisphere phase II dosimetry trial supports MAA single photon emission computed tomography (SPECT)/CT-based prospective personalized dosimetry2.
Innovation is trending toward improved efficiency — but not at the expense of patient safety, according to Michael Perez ...
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Injector technology development carries on the evolution of contrast agents
The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of Directors. Laura Dawson, M.D., FASTRO, will begin her term as president-elect in September during ASTRO’s 61st Annual Meeting, Sept. 15-18 in Chicago, alongside Neha Vapiwala, M.D., the new secretary/treasurer-elect; Constantine Mantz, M.D., the new health policy council vice-chair; and Brian Marples, Ph.D., the new science council vice-chair.
SuperSonic Imagine announced the publication of the results of its prospective multicentric clinical study conducted in China to validate the performance of ShearWave Elastography (SWE) in evaluating liver fibrosis severity in patients with chronic hepatitis B (HBV). SWE enables tissue stiffness to be instantly visualised and measured in kPa. The results of the study were published in two articles that appeared in the peer-reviewed journals, Radiology and Gut.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Nate Bachman, graduate research assistant in the Human Cardiovascular Physiology Lab of the Dept. of Health and Exercise ...
Pierre Qian, MBBS, cardiac electrophysiologist fellow, Brigham and Women's Hospital, explains how his facility is ...
Mark Ibrahim, M.D., FACC, assistant professor of medicine and radiology, associate program director, advanced cardiac ...
Arthur Agatston, M.D., clinical professor of medicine, Florida International University, Herbert Wertheim College of ...
Cynthia McCollough, Ph.D., director of the Mayo Clinic CT Clinical Innovation Center, professor of medical physics and ...
Philips and Centre Hospitalier Régional Universitaire (CHRU) de Nancy, a leading academic hospital in the Grand Est region of France, recently announced a 10-year agreement to implement Philips’ IntelliSpace Enterprise Imaging Solution, including Illumeo with adaptive intelligence.
Scientists at Dana-Farber Cancer Institute have demonstrated that an artificial intelligence (AI) tool can perform as well as human reviewers – and much more rapidly - in extracting clinical information regarding changes in tumors from unstructured radiology reports for patients with lung cancer.
Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest, neck or head had significantly reduced risk of suffering a stroke, and possibly other cardiovascular complications, according to new research. The research appeared in Journal of the American Heart Association.